Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Follicular Lymphoma Response with CDK4/6 Inhibitor(Palbociclib) Utilized in the Setting of Metastatic Breast Cancer

Syed S Ali, Wilson Mertens

Blood (2017) 130 (Supplement 1): 5165.

https://doi.org/10.1182/blood.V130.Suppl_1.5165.5165

Published: 2017

Journal Articles

Secondary Myeloid Neoplasms in Older Women with Breast Cancer after Radiotherapy: A Population-Based Study

Amer M. Zeidan, MBBS, MHS, Jessica B. Long, PhD, Rong Wang, PhD, James B. Yu, MD, Jane Hall, Gregory Abel, MD MPH, Steven D. Gore, MD, Cary P. Gross, MD, Xiaomei Ma, PhD, Amy J. Davidoff, PhD

Blood (2015) 126 (23): 1676.

https://doi.org/10.1182/blood.V126.23.1676.1676

Published: 2015

Journal Articles

Chronic Neutrophilic Leukemia With Concurrent CSF3R and SETBP1 Mutations: Single Colony Clonality Studies, In Vitro Sensitivity To JAK Inhibitors and Lack Of Treatment Response To Ruxolitinib

Terra L Lasho, MT, (ASCP), Alice Mims, MD, Rebecca R. Laborde, PhD, Christy Finke, BS, Animesh Pardanani, MBBS, PhD, Ayalew Tefferi, MD

Blood (2013) 122 (21): 2830.

https://doi.org/10.1182/blood.V122.21.2830.2830

Published: 2013

Journal Articles

Therapy-Related Myelodysplasia/Acute Myeloid Leukemia (t-MDS/AML) After Conventionally-Treated Breast Cancer: Impact of Cytogenetics on Outcome After Allogeneic Hematopoietic Cell Transplantation (HCT),

Rajinder S. Grover, MD, Vinod Pullarkat, MD, Can-Lan Sun, PhD, Smita Bhatia, MD, MPH, Stephen J. Forman, MD

Blood (2011) 118 (21): 4149.

https://doi.org/10.1182/blood.V118.21.4149.4149

Published: 2011

Journal Articles

Breast Cancer Patients Undergoing Adjuvant Chemotherapy Do Not Acquire Activated Protein C Resistance (APC-R).

Madhu N Belur Shivananda, MBBS, MD, Theodore Bell, MS, Edith Sielsch, CRNP, Diane Gaspari, Amir Tabatabai, MD

Blood (2009) 114 (22): 5058.

https://doi.org/10.1182/blood.V114.22.5058.5058

Published: 2009

Journal Articles

Localized AL Amyloidosis of the Breast: A Case Series.

Marjory Charlot, MD, David C. Seldin, MD, PhD, Carl O'Hara, MD, Martha Skinner, MD, Vaishali Sanchorawala, MD

Blood (2009) 114 (22): 4906.

https://doi.org/10.1182/blood.V114.22.4906.4906

Published: 2009

Journal Articles

Do Aromatase Inhibitors Increase Hemoglobin in Women with Breast Cancer?

Daniel J. Lachant, BS, Kanu P. Sharan, MD, Andres Ferber, MD, Robert Somer, MD, Generosa Grana, MD, Neil A. Lachant, MD

Blood (2008) 112 (11): 4575.

https://doi.org/10.1182/blood.V112.11.4575.4575

Published: 2008

Journal Articles

A Case Illustrating That Cancer Tips the Scale of Thrombosis.

Emma C. Scott, MD, Jeffrey Cohn, MD, Stephen Heitner, MD

Blood (2005) 106 (11): 4128.

https://doi.org/10.1182/blood.V106.11.4128.4128

Published: 2005

NARROW

Follicular Lymphoma Response with CDK4/6 Inhibitor(Palbociclib) Utilized in the Setting of Metastatic Breast Cancer

Secondary Myeloid Neoplasms in Older Women with Breast Cancer after Radiotherapy: A Population-Based Study

Chronic Neutrophilic Leukemia With Concurrent CSF3R and SETBP1 Mutations: Single Colony Clonality Studies, In Vitro Sensitivity To JAK Inhibitors and Lack Of Treatment Response To Ruxolitinib

Therapy-Related Myelodysplasia/Acute Myeloid Leukemia (t-MDS/AML) After Conventionally-Treated Breast Cancer: Impact of Cytogenetics on Outcome After Allogeneic Hematopoietic Cell Transplantation (HCT),

Breast Cancer Patients Undergoing Adjuvant Chemotherapy Do Not Acquire Activated Protein C Resistance (APC-R).

Localized AL Amyloidosis of the Breast: A Case Series.

Do Aromatase Inhibitors Increase Hemoglobin in Women with Breast Cancer?

A Case Illustrating That Cancer Tips the Scale of Thrombosis.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only